Genmab reported 554M in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Agios Pharmaceuticals AGIO:US $ 1.06M 0.78M
Amarin AMRN:US $ 0M 0M
Amgen AMGN:US $ 35705M 305M
AstraZeneca AZN:LN 27146M 1659M
Bayer BAYN:GR € 38061M 1413M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Bluebird Bio BLUE:US $ 0M 0M
Fresenius Medical Care FME:GR € 11483M 14.2M
Galapagos GLPG:NA 16.88M 1.41M
Genmab GEN:DC 554M 198M
GlaxoSmithKline GSK:LN 18784M 10442M
Hikma Pharmaceutical HIK:LN 1.41B 689M
Insmed INSM:US $ 807.11M 447K
Lonza Group LONN:SW 1.95B 287M
Merck MRK:GR € 9385M 1099M
Novartis NOVN:VX SF 23784M 589M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Seattle Genetics SGEN:US $ 0M 0M